Skip to main content
. 1999 Jul;127(5):1083–1090. doi: 10.1038/sj.bjp.0702634

Figure 4.

Figure 4

(A) Effects of prior depletion of mast cells (through pre-treatment with compound 48/80) on the increase in hindpaw volume following injection of PAR2-activating peptides (tc-NH2, 100 μg or SL-NH2 500 μg) or a control peptide (LS-NH2, 100 μg). Asterisks denote significant differences (P<0.05) from the corresponding group not treated with compound 48/80. (B) Effects of mast cell stabilization (through pre-treatment with cromolyn) on the increase in hindpaw volume following injection of PAR2-activating peptides (tc-NH2, 100 μg or SL-NH2 500 μg) or a control peptide (LS-NH2, 100 μg). Asterisks denote significant differences (P<0.05) from the corresponding group not treated with cromolyn.